Effect of food on the bioavailability of labetalol.
作者信息
Mäntylä R, Allonen H, Kanto J, Kleimola T, Sellman R
出版信息
Br J Clin Pharmacol. 1980 Apr;9(4):435-7. doi: 10.1111/j.1365-2125.1980.tb01076.x.
Abstract
摘要
相似文献
1
Effect of food on the bioavailability of labetalol.食物对拉贝洛尔生物利用度的影响。
Br J Clin Pharmacol. 1980 Apr;9(4):435-7. doi: 10.1111/j.1365-2125.1980.tb01076.x.
2
The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.食物对高清除率药物口服及静脉药代动力学的影响：拉贝洛尔的研究
Br J Clin Pharmacol. 1982 Jul;14(1):73-8. doi: 10.1111/j.1365-2125.1982.tb04936.x.
3
Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.美多心安与拉贝洛尔的临床药代动力学及浓度-效应关系比较。
Br J Clin Pharmacol. 1984 May;17(5):573-8. doi: 10.1111/j.1365-2125.1984.tb02392.x.
4
Bioavailability of labetalol increases with age.拉贝洛尔的生物利用度随年龄增长而增加。
Br J Clin Pharmacol. 1982 Aug;14(2):304-5. doi: 10.1111/j.1365-2125.1982.tb01983.x.
5
Single-dose pharmacokinetics of labetalol in healthy young men.拉贝洛尔在健康年轻男性中的单剂量药代动力学。
Acta Med Scand Suppl. 1982;665:67-73. doi: 10.1111/j.0954-6820.1982.tb00410.x.
6
Decreased first-pass metabolism of labetalol in chronic liver disease.慢性肝病中拉贝洛尔首过代谢降低。
Br Med J. 1978 Oct 14;2(6144):1048-50. doi: 10.1136/bmj.2.6144.1048.
7
The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.酶诱导和酶抑制对拉贝洛尔药代动力学的影响。
Br J Clin Pharmacol. 1984 Sep;18(3):393-400. doi: 10.1111/j.1365-2125.1984.tb02481.x.
8
Clinical pharmacokinetics of labetalol.拉贝洛尔的临床药代动力学
Clin Pharmacokinet. 1984 Mar-Apr;9(2):157-67. doi: 10.2165/00003088-198409020-00003.
9
Cimetidine and bioavailability of labetalol.西咪替丁与拉贝洛尔的生物利用度
Lancet. 1981 Mar 7;1(8219):565. doi: 10.1016/s0140-6736(81)92903-2.
10
Clinical and pharmacokinetic studies on the alpha- and beta-blocking drug labetalol.
Ther Drug Monit. 1980;2(2):145. doi: 10.1097/00007691-198004000-00006.
引用本文的文献
1
Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women.基于生理的拉贝洛尔多次口服给药在孕妇中的药代动力学模型。
Pharm Res. 2023 Jul;40(7):1765-1775. doi: 10.1007/s11095-023-03523-y. Epub 2023 May 4.
2
Individual variation in first-pass metabolism.首过代谢的个体差异。
Clin Pharmacokinet. 1993 Oct;25(4):300-28. doi: 10.2165/00003088-199325040-00005.
3
The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.食物对高清除率药物口服及静脉药代动力学的影响：拉贝洛尔的研究
Br J Clin Pharmacol. 1982 Jul;14(1):73-8. doi: 10.1111/j.1365-2125.1982.tb04936.x.
4
The influence of food intake on the bioavailability of timegadine, a novel non-steroidal anti-inflammatory drug.
Br J Clin Pharmacol. 1983 Apr;15(4):495-8. doi: 10.1111/j.1365-2125.1983.tb01537.x.
5
Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers.
Eur J Clin Pharmacol. 1983;24(2):227-30. doi: 10.1007/BF00613822.
6
Interactions affecting drug absorption.影响药物吸收的相互作用。
Clin Pharmacokinet. 1984 Sep-Oct;9(5):404-34. doi: 10.2165/00003088-198409050-00002.
7
Clinical pharmacokinetics of labetalol.拉贝洛尔的临床药代动力学
Clin Pharmacokinet. 1984 Mar-Apr;9(2):157-67. doi: 10.2165/00003088-198409020-00003.
8
First-pass elimination. Basic concepts and clinical consequences.首过消除。基本概念及临床后果。
Clin Pharmacokinet. 1984 Jan-Feb;9(1):1-25. doi: 10.2165/00003088-198409010-00001.
9
Pharmacology of combined alpha-beta-blockade. I.α-β联合阻滞的药理学。I.
Drugs. 1984;28 Suppl 2:16-34. doi: 10.2165/00003495-198400282-00003.
10
Physiological and pharmacological variability in estimated hepatic blood flow in man.人体肝脏血流估计中的生理和药理变异性。
Br J Clin Pharmacol. 1981 May;11(5):491-6. doi: 10.1111/j.1365-2125.1981.tb01155.x.
本文引用的文献
1
The effect of oral protein and glucose feeding of splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects.口服蛋白质和葡萄糖对正常人和肝硬化患者内脏血流及氧利用的影响。
J Clin Invest. 1955 Jul;34(7, Part 1):1017-25. doi: 10.1172/JCI103151.
2
Influence of first-pass effect on availability of drugs on oral administration.首过效应对口服给药时药物可利用度的影响。
J Pharm Sci. 1971 Sep;60(9):1338-40. doi: 10.1002/jps.2600600909.
3
Altered absorption of digoxin in patients given propantheline and metoclopramide.接受丙胺太林和甲氧氯普胺治疗的患者地高辛吸收发生改变。
Lancet. 1973 Feb 24;1(7800):398-400. doi: 10.1016/s0140-6736(73)90252-3.
4
Metabolism of labetalol by animals and man.拉贝洛尔在动物和人体内的代谢。
Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):695-710.
5
Enhancement of the bioavailability of propranolol and metoprolol by food.食物对普萘洛尔和美托洛尔生物利用度的增强作用。
Clin Pharmacol Ther. 1977 Jul;22(1):108-12. doi: 10.1002/cpt1977221108.
6
Decreased first-pass metabolism of labetalol in chronic liver disease.慢性肝病中拉贝洛尔首过代谢降低。
Br Med J. 1978 Oct 14;2(6144):1048-50. doi: 10.1136/bmj.2.6144.1048.
7
Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism.食物、内脏血流量与受首过代谢影响药物的生物利用度。
Clin Pharmacol Ther. 1978 Jul;24(1):5-10. doi: 10.1002/cpt19782415.
8
The effect of crystal size, gastric content and emptying rate on the absorption of nitrofurantoin in healthy human volunteers.晶体大小、胃内容物及排空率对健康人体志愿者中呋喃妥因吸收的影响。
Int J Clin Pharmacol Biopharm. 1978 May;16(5):223-8.
9
Influence of food and diet on gastrointestinal drug absorption: a review.食物和饮食对胃肠道药物吸收的影响：综述
J Pharmacokinet Biopharm. 1977 Aug;5(4):291-334. doi: 10.1007/BF01061694.
10
Influence of food on the bioavailability of drugs.食物对药物生物利用度的影响。
Clin Pharmacokinet. 1978 Sep-Oct;3(5):337-51. doi: 10.2165/00003088-197803050-00001.
Zotero 插件